Detailed price information for Nanoviricides Inc (NNVC-A) from The Globe and Mail including charting and trades.
Signs Master Services Agreement With Only Orphans Cote For NV-387 Orphan Drug Strategy. NanoViricides, Inc. (NYSE American: NNVC), a clinical stage global pioneer in broad-spectrum antivirals based on ...
In the 1980s, the human immunodeficiency virus (HIV) was a global scourge, decimating communities. When it was identified in the blood products supply chain, people were terrified.
Infectious diseases such as bacterial, viral, fungal and parasitic diseases continue to have a significant impact on global health. Hence, knowledge on how infection spread, population vulnerable to ...
Healthbeat on MSN
How the Global Fund might cover a $6.7B shortfall in donations
This week’s Global Health Checkup has an unexpected through-line. Several stories reveal how the global health system is preparing for a long season of austerity: from staff cuts at the World Health ...
Island Pharmaceuticals Ltd ( ($AU:ILA) ) has provided an announcement. Island Pharmaceuticals Ltd has been granted a US patent for the use of ...
The company's Check4 electrochemical detection platform can detect nucleic acid targets from blood or saliva samples in less than five minutes.
KINSHASA, Congo -- Congo announced the end of the country's 16th Ebola outbreak on Monday. “To date, the DRC has 53 confirmed ...
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack ...
Mass General Brigham researchers engineer a virus that destroys brain tumor cells while avoiding healthy brain tissue ...
News-Medical.Net on MSN
Engineered herpes virus activates potent immune responses against glioblastoma
Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results